Compare KZR & VVPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KZR | VVPR |
|---|---|---|
| Founded | 2015 | 2014 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Power Generation |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 45.8M | 40.2M |
| IPO Year | 2018 | 2016 |
| Metric | KZR | VVPR |
|---|---|---|
| Price | $6.20 | $2.74 |
| Analyst Decision | Hold | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | 34.0K | ★ 389.1K |
| Earning Date | 11-12-2025 | 09-02-2023 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $61,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 281.25 |
| 52 Week Low | $3.53 | $0.62 |
| 52 Week High | $6.65 | $8.88 |
| Indicator | KZR | VVPR |
|---|---|---|
| Relative Strength Index (RSI) | 47.69 | N/A |
| Support Level | $6.04 | N/A |
| Resistance Level | $6.27 | N/A |
| Average True Range (ATR) | 0.10 | 0.00 |
| MACD | -0.03 | 0.00 |
| Stochastic Oscillator | 33.33 | 0.00 |
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.
Vivopower International PLC is a sustainable energy solutions B Corporation specializing in electric solutions for customized and ruggedized fleet applications, battery and microgrids, solar, and critical power technology and services. The company's core purpose is to provide turnkey decarbonization solutions that help customers progress toward net-zero carbon status. VivoPower operates across five reportable segments: Electric Vehicles, Sustainable Energy Solutions, Solar Development, Digital Assets, and Corporate Office, with personnel and operations in Australia, the Netherlands, the United Kingdom, the United States, and the Philippines.